Top

Health Surveys

QualityMetric’s PRO health surveys

QualityMetric designs valid and versatile patient-reported outcome (PRO) measurement tools that capture, analyze and interpret the impact and health outcomes of various conditions, coupling meaningful data with multidisciplinary research expertise to gain a deeper understanding of patient experiences and preferences. Top life sciences, pharma and biotech companies utilize PRO survey solutions to accelerate product development and deliver precise treatments and therapies that are true to the voice that matters most—the patient.

In addition to providing the initial assessment of an individual’s health status, our PRO surveys can evaluate treatment effectiveness, differentiate between outcomes produced by a wide range of treatments, enable evaluation of treatment benefits in relation to health costs and utilization of services and meaningfully engage the consumer in the healthcare process.

Our high-value health outcome surveys can be used in pharmacoeconomic analysis, clinical trials, direct-to-consumer (DTC) marketing, disease and population management, risk assessment, cost prediction and consumer-directed healthcare initiatives.

Our suite of PRO surveys

Available in over 2,000 translations across multiple modes of administration, our patient-reported outcome surveys allow researchers and investigators to include the voice of the patient in their studies and treatment trials from all over the world, enabling an unbiased view on health outcomes and study results. Our trusted network of U.S.-based linguists and translators has extensive knowledge in end-to-end drug development and country-specific guidelines, so we can enable each target population to interpret translated items exactly as intended.

Pediatric-Specific PRO Surveys

For evaluating a child’s general health as well as the effect of certain diseases on their quality of life.


Fit-for-Purpose Surveys

For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.


Custom PRO Surveys

For measurement that is specific to your project or condition-related goals, whether you require an entirely new PRO survey or modifications to an existing survey.


Expertise in over 60 therapeutic areas.

Comprised of multidisciplinary scientists, researchers and health experts around the globe, our team has decades of experience in diverse therapeutic areas, including:

Rare Disease
Immunology
Oncology
Behavioral Health
Chronic Diseases

Enhancing your decision-making processes

Our high-quality, regulatory-compliant data will better inform your processes and improve your ability to address health-related outcomes.

DRUG PERFORMANCE

Measure and monitor the effectiveness of treatments, medical devices and programs over time.

DISEASE BURDEN

Understand the full impact of diseases on patients and defined populations.

COMPARATIVE EFFECTIVENESS

Make risk-adjusted comparisons across treatments, providers, programs, and patients.

PATIENT LIFECYCLE

Evaluate unmet needs and identify opportunities to increase the length and quality of patients’ lives.

FUTURE RISKS

Predict the future health utilization and medical expenditures of certain patients.

HEALTH FLUCTUATION

Measure and monitor health improvement or decline as well as the velocity of change over time.

LABEL CLAIMS

Incorporate the patient’s experience in product label and marketing claims.



Benefiting the product lifecycle

Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.

Commercial
Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Phase I
Assist with PRO/COA and clinical end development; outcome measures selection; the review and synthesis of evidence for specific measures; and the development and psychometric evaluation of new measures for testing in Phase II.
Phase II
Assist with preparation for End of Phase 2 meetings; COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase III
Assist with COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase IV
Assist with strategy, design, endpoints, and analysis for real-world studies; Electronic Data Capture solution for real-world studies; analysis and interpretation of PRO results; Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Registries
Develop measurement strategy that contributes to the body of evidence for all stakeholders. Characterize and quantify treatment benefit using PRO, ClinRO, ObsRO.
Benefiting the product lifecycle

Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.

Commercial
Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Phase I
Assist with PRO/COA and clinical end development; outcome measures selection; the review and synthesis of evidence for specific measures; and the development and psychometric evaluation of new measures for testing in Phase II.
Phase II
Assist with preparation for End of Phase 2 meetings; COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase III
Assist with COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase IV
Assist with strategy, design, endpoints, and analysis for real-world studies; Electronic Data Capture solution for real-world studies; analysis and interpretation of PRO results; Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Registries
Develop measurement strategy that contributes to the body of evidence for all stakeholders. Characterize and quantify treatment benefit using PRO, ClinRO, ObsRO.